Kidney transplant rejection

• A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting
  2025-521521-33-00 10 2026-04-02
• Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting
  2022-500230-28-00 4 2023-06-02 "Highly sensitised paediatric patients with a positive crossm"
• A Trial of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) Recruitment ended
  2024-519095-66-00 5 2025-07-23 "Kidney Transplant Recipients with Late Antibody-Mediated Rej"
• BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long- Term Safety and Efficacy of Tegoprubart in Kidney … Recruitment ended
  2023-503337-21-00 4 2025-02-28 "Prophylaxis of Renal Allograft Rejection"
• A long-term follow-up trial of patients previously treated with imlifidase prior to kidney transplantation and a non-comparative transplante … Recruitment ended
  2022-502727-21-00 5 2023-07-03 "Highly sensitised patients who have undergone kidney transpl"
• Crossover study to investigate the safety and tolerability as well as the blood levels after three single doses of Tacrolimus, of which 2 ar … Ended
  2025-525076-29-00 3 2026-03-23 "Phase I study in healthy male volunteers. Intended indicatio"
• BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidne … Ended
  2023-503336-41-00 4 2023-11-29 "Prophylaxis of Renal Allograft Rejection"
• Study in highly sensitised kidney transplant patients with a high degree of antibodies against the donor's kidney to see the efficacy and sa … Ended
  2024-511810-18-00 5 2022-04-19 "End stage chronic kidney disease (CKD) patients who are high"

Showing 1–8 of 8 trials